Literature DB >> 10454787

Parvovirus glomerulonephritis in a patient with sickle cell disease.

A Tolaymat1, F Al Mousily, K MacWilliam, N Lammert, B Freeman.   

Abstract

A child with sickle cell disease developed glomerulonephritis 10 days following an aplastic crisis induced by human parvovirus B 19 infection. An initial kidney biopsy showed focal proliferative glomerulonephritis, and 1 year later was compatible with focal and segmental glomerulosclerosis. Renal tissue, tested by polymerase chain reaction, was positive for parvovirus, while the patient's blood was negative. For the first time a direct relationship has been demonstrated between parvovirus infection and glomerulonephritis.

Entities:  

Mesh:

Year:  1999        PMID: 10454787     DOI: 10.1007/s004670050622

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  5 in total

1.  Nephrotic syndrome associated with human parvovirus B19 infection.

Authors:  Yoshiyuki Ohtomo; Risako Kawamura; Kazunari Kaneko; Yuichiro Yamashiro; Nobutaka Kiyokawa; Tomoko Taguchi; Kenichi Mimori; Junichiro Fujimoto
Journal:  Pediatr Nephrol       Date:  2003-02-12       Impact factor: 3.714

Review 2.  Viruses and kidney disease: beyond HIV.

Authors:  Meryl Waldman; Vickie Marshall; Denise Whitby; Jeffrey B Kopp
Journal:  Semin Nephrol       Date:  2008-11       Impact factor: 5.299

3.  Simultaneous acute splenic sequestration and transient aplastic crisis in children with sickle cell disease.

Authors:  Amber Mayfield Yates; Jane S Hankins; Nicole A Mortier; Banu Aygun; Russell E Ware
Journal:  Pediatr Blood Cancer       Date:  2009-09       Impact factor: 3.167

Review 4.  Viruses and collapsing glomerulopathy: a brief critical review.

Authors:  Preeti Chandra; Jeffrey B Kopp
Journal:  Clin Kidney J       Date:  2012-01-01

5.  Fat Embolism Syndrome in Sickle Cell Disease.

Authors:  Dimitris A Tsitsikas; Jessica Vize; Jibril Abukar
Journal:  J Clin Med       Date:  2020-11-08       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.